Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

OBJECTIVE: Short-term efficacy of induction therapy with intravenous immunoglobulin (Ig) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) is well established. However, data of previous studies on maintenance therapy were limited up to 24-week treatment period. We aimed to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwabara, Satoshi, Mori, Masahiro, Misawa, Sonoko, Suzuki, Miki, Nishiyama, Kazutoshi, Mutoh, Tatsuro, Doi, Shizuki, Kokubun, Norito, Kamijo, Mikiko, Yoshikawa, Hiroo, Abe, Koji, Nishida, Yoshihiko, Okada, Kazumasa, Sekiguchi, Kenji, Sakamoto, Ko, Kusunoki, Susumu, Sobue, Gen, Kaji, Ryuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Neuromuscular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629934/
https://www.ncbi.nlm.nih.gov/pubmed/28768822
http://dx.doi.org/10.1136/jnnp-2017-316427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629934/
https://www.ncbi.nlm.nih.gov/pubmed/28768822
http://dx.doi.org/10.1136/jnnp-2017-316427

Ejemplares similares